Drug safety updates from Ireland health authority (HPRA)-May 2020

Drug Safety Alert, Drug Safety Updates, Pharmacovigilance, Safety Communications, Voluntary ADR reporting, ,

Below Safety Updates for medicinal products were released for the month of May-2020 by Ireland Health Authority-Health Products Regulatory Agency (HPRA)   A confirmed “Negative Benefit-Risk Profile” for Picato (ingenol mebutate) Risk of abnormal and aggressive behaviors with Levetiracetam use Restricted use of Cyproterone acetate due to risk of meningioma Restricted use of thyroid drugs…

Read More

Voluntary reporting of medicine side effects from Public

Pharmacovigilance, Voluntary ADR reporting, , , ,

Spontaneous reporting of adverse effects/reactions/experiences of medicinal products is quite essential for generating the safety information of a medicine (for both new & well established medicinal products). Voluntary side effects reporting is a significant source for real world drug safety experience. A transparent benefit risk profile for a pharmaceutical medicinal product can be achieved through…

Read More

error: Content is protected !!